Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2). - Concepedia

Concepedia

Publication | Closed Access

Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2).

13

Citations

0

References

1999

Year

Mohamed Abdel Wahab, F el-Shennawy, Seyed Hossein Seyed Agha, Esraa Ragab, O Fathi, Ahmed Sultan, N el-Ghawalby, F Ezzat

Abstract

Immunotherapy is a new modality for treatment of pancreatic carcinoma. Local administration of therapy seems to be an attractive way for delivering the optimum concentration of IL-2 target tissues avoiding the toxic side effects associated with high dose systemic treatment.